606 related articles for article (PubMed ID: 15099659)
21. CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats.
Rubio M; Fernández-Ruiz J; de Miguel R; Maestro B; Michael Walker J; Ramos JA
Neuropharmacology; 2008 May; 54(6):976-88. PubMed ID: 18371990
[TBL] [Abstract][Full Text] [Related]
22. Novel behavioral assays of spontaneous and precipitated THC withdrawal in mice.
Trexler KR; Nass SR; Crowe MS; Gross JD; Jones MS; McKitrick AW; Siderovski DP; Kinsey SG
Drug Alcohol Depend; 2018 Oct; 191():14-24. PubMed ID: 30071445
[TBL] [Abstract][Full Text] [Related]
23. The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons.
Romero J; García L; Cebeira M; Zadrozny D; Fernández-Ruiz JJ; Ramos JA
Life Sci; 1995; 56(23-24):2033-40. PubMed ID: 7776829
[TBL] [Abstract][Full Text] [Related]
24. Role of the endocannabinoid system in the development of tolerance to alcohol.
Basavarajappa BS; Hungund BL
Alcohol Alcohol; 2005; 40(1):15-24. PubMed ID: 15550443
[TBL] [Abstract][Full Text] [Related]
25. Early tolerance to the hypophagic effect of the cannabinoid receptor antagonist SR141716 does not impede blockade of an orexigenic stimulus.
Rigamonti AE; Giordani C; Bonomo SM; Cella SG; Müller EE
Eur J Pharmacol; 2006 Aug; 542(1-3):116-20. PubMed ID: 16806163
[TBL] [Abstract][Full Text] [Related]
26. Changes in rat brain energetic metabolism after exposure to anandamide or Delta(9)-tetrahydrocannabinol.
Costa B; Colleoni M
Eur J Pharmacol; 2000 Apr; 395(1):1-7. PubMed ID: 10781666
[TBL] [Abstract][Full Text] [Related]
27. Paraventricular hypothalamic CB(1) cannabinoid receptors are involved in the feeding stimulatory effects of Delta(9)-tetrahydrocannabinol.
Verty AN; McGregor IS; Mallet PE
Neuropharmacology; 2005 Dec; 49(8):1101-9. PubMed ID: 16098995
[TBL] [Abstract][Full Text] [Related]
28. Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects.
Ellgren M; Artmann A; Tkalych O; Gupta A; Hansen HS; Hansen SH; Devi LA; Hurd YL
Eur Neuropsychopharmacol; 2008 Nov; 18(11):826-34. PubMed ID: 18674887
[TBL] [Abstract][Full Text] [Related]
29. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.
Di Marzo V; Breivogel CS; Tao Q; Bridgen DT; Razdan RK; Zimmer AM; Zimmer A; Martin BR
J Neurochem; 2000 Dec; 75(6):2434-44. PubMed ID: 11080195
[TBL] [Abstract][Full Text] [Related]
30. CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol.
Cook SA; Lowe JA; Martin BR
J Pharmacol Exp Ther; 1998 Jun; 285(3):1150-6. PubMed ID: 9618417
[TBL] [Abstract][Full Text] [Related]
31. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal.
Rodríguez de Fonseca F; Carrera MR; Navarro M; Koob GF; Weiss F
Science; 1997 Jun; 276(5321):2050-4. PubMed ID: 9197270
[TBL] [Abstract][Full Text] [Related]
32. Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia.
Suplita RL; Eisenstein SA; Neely MH; Moise AM; Hohmann AG
Neuropharmacology; 2008 Jan; 54(1):161-71. PubMed ID: 17714742
[TBL] [Abstract][Full Text] [Related]
33. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
[TBL] [Abstract][Full Text] [Related]
34. Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice.
Huang P; Liu-Chen LY; Unterwald EM; Cowan A
Neurosci Lett; 2009 Nov; 465(1):66-70. PubMed ID: 19733208
[TBL] [Abstract][Full Text] [Related]
35. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol.
Romero J; Berrendero F; Manzanares J; Pérez A; Corchero J; Fuentes JA; Fernández-Ruiz JJ; Ramos JA
Synapse; 1998 Nov; 30(3):298-308. PubMed ID: 9776133
[TBL] [Abstract][Full Text] [Related]
36. Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates.
Justinova Z; Mangieri RA; Bortolato M; Chefer SI; Mukhin AG; Clapper JR; King AR; Redhi GH; Yasar S; Piomelli D; Goldberg SR
Biol Psychiatry; 2008 Dec; 64(11):930-7. PubMed ID: 18814866
[TBL] [Abstract][Full Text] [Related]
37. Possible inhibitory roles of endogenous 2-arachidonoylglycerol during corticotropin-releasing factor-induced activation of central sympatho-adrenomedullary outflow in anesthetized rats.
Shimizu T; Lu L; Yokotani K
Eur J Pharmacol; 2010 Sep; 641(1):54-60. PubMed ID: 20519139
[TBL] [Abstract][Full Text] [Related]
38. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A.
Welch SP; Huffman JW; Lowe J
J Pharmacol Exp Ther; 1998 Sep; 286(3):1301-8. PubMed ID: 9732392
[TBL] [Abstract][Full Text] [Related]
39. Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function.
Romero J; de Miguel R; García-Palomero E; Fernández-Ruiz JJ; Ramos JA
Brain Res; 1995 Oct; 694(1-2):223-32. PubMed ID: 8974649
[TBL] [Abstract][Full Text] [Related]
40. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity.
Katsidoni V; Kastellakis A; Panagis G
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
